These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11048895)

  • 1. Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors.
    Hayden JM; Reaven PD
    Curr Opin Lipidol; 2000 Oct; 11(5):519-28. PubMed ID: 11048895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.
    Yamagishi S; Nakamura K; Takeuchi M; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(4):129-34. PubMed ID: 15754918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture.
    Cooper ME; El-Osta A; Allen TJ; Watson AMD; Thomas MC; Jandeleit-Dahm KAM
    Diabetes; 2018 May; 67(5):785-790. PubMed ID: 29678824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation, oxidation, and lipoxidation in the development of diabetic complications.
    Kennedy AL; Lyons TJ
    Metabolism; 1997 Dec; 46(12 Suppl 1):14-21. PubMed ID: 9439553
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.
    Makita Z; Yanagisawa K; Kuwajima S; Bucala R; Vlassara H; Koike T
    Nephrol Dial Transplant; 1996; 11 Suppl 5():31-3. PubMed ID: 9044304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic macrovascular disease: the glucose paradox?
    Libby P; Plutzky J
    Circulation; 2002 Nov; 106(22):2760-3. PubMed ID: 12450998
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update.
    Piarulli F; Sartore G; Lapolla A
    Acta Diabetol; 2013 Apr; 50(2):101-10. PubMed ID: 22763581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-prandial hyperglycaemia and vascular disease.
    Hanefeld M
    Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease risk in youth with diabetes mellitus.
    Wadwa RP
    Rev Endocr Metab Disord; 2006 Sep; 7(3):197-204. PubMed ID: 17160723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.
    Gray SP; Jandeleit-Dahm K
    J Mol Med (Berl); 2014 May; 92(5):441-52. PubMed ID: 24687627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
    Xu Y; He Z; King GL
    Curr Diab Rep; 2005 Apr; 5(2):91-7. PubMed ID: 15794910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome.
    Rett K
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S8-16. PubMed ID: 11220289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
    Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual renal and cardiovascular disease risk in conventionally-treated patients with type 2 diabetes: the potential of non-traditional biomarkers.
    Zitouni K; Steyn M; Earle KA
    Minerva Med; 2018 Apr; 109(2):103-115. PubMed ID: 29164839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More sugar, less blood vessels: another piece in the puzzle of increased cardiovascular risk in diabetes.
    Rask-Madsen C; King GL
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):608-10. PubMed ID: 18354093
    [No Abstract]   [Full Text] [Related]  

  • 18. Dicarbonyl Stress in Diabetic Vascular Disease.
    Stratmann B
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.
    Lee J; Yun JS; Ko SH
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular disease in diabetes mellitus: classical and non-classical risk factors].
    Siqueira AF; Almeida-Pititto Bd; Ferreira SR
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):257-67. PubMed ID: 17505632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.